MidWest Drug Development Conference
Downtown Capitol District, Omaha, Neb. | Oct. 4-5, 2021
2021-10-04 08:00:00
Register!
Downloads
  • Map & Other Info (Coming soon!)
  • Brochure (Coming soon!)
  • Flyer (Coming soon!)
  • 2021 Program (Coming soon!)
  • 2019 Program
  • 2018 Program
  • Home
  • Schedule
  • Venue
  • Technologies
    • Technologies
    • Institutions
    • Startups
    • Previous Technologies
  • Sponsors
  • News
  • Contact
  • Home
  • Schedule
  • Venue
  • Technologies
    • Technologies
    • Institutions
    • Startups
    • Previous Technologies
  • Sponsors
  • News
  • Contact

Antitoxin peptides inhibit clostridium difficile

University of Oklahoma

Researchers at the University of Oklahoma have discovered a class of antitoxin peptides that inhibit a critical clostridium difficile virulence factor.

The lead peptide inhibits cytotoxicity of clostridium difficile toxin B on CHO-K1 cells through a structural conformational change that subsequently prevents the toxins from entering host cells. This technology presents a pathway for the development of novel peptide inhibitors for treatment of clostridium difficile associated disease.

Logo

MIDWEST DRUG DEVELOPMENT CONFERENCE
Bringing together industry and the best university drug development researchers in the Midwest
Downtown Capitol District, Omaha, NE
Oct. 4-5, 2021

Latest News
  • Registrations are now open for 2021 March 25, 2021
  • Planners set initial slate of participants, more to come February 22, 2021
  • MidWest Drug Development Conference plans to return in 2021 January 11, 2021
  • MidWest Drug Development Conference for 2020 is postponed July 15, 2020
Twitter Hightlights
  • 👀 https://t.co/WWaZ16hOhr https://t.co/XErdmyAequ
    5 days ago
  • RT @SharpIdeaHub: Drive change in the world with your research - Attend ABC of #SBIR/#STTR #Funding on April 21 at 8:30 am CST Register: ht…
    6 days ago